Cargando…
Cell foundry with high product specificity and catalytic activity for 21-deoxycortisol biotransformation
BACKGROUND: 21-deoxycortisol (21-DF) is the key intermediate to manufacture pharmaceutical glucocorticoids. Recently, a Japan patent has realized 21-DF production via biotransformation of 17-hydroxyprogesterone (17-OHP) by purified steroid 11β-hydroxylase CYP11B1. Due to the less costs on enzyme iso...
Autores principales: | Xiong, Shuting, Wang, Ying, Yao, Mingdong, Liu, Hong, Zhou, Xiao, Xiao, Wenhai, Yuan, Yingjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470312/ https://www.ncbi.nlm.nih.gov/pubmed/28610588 http://dx.doi.org/10.1186/s12934-017-0720-y |
Ejemplares similares
-
Compartmentalization engineering of yeasts to overcome precursor limitations and cytotoxicity in terpenoid production
por: Chen, Lifei, et al.
Publicado: (2023) -
SAT-LB13 Clinical Utility of 21-Deoxycortisol in Congenital Adrenal Hyperplasia
por: Curtin, Bill, et al.
Publicado: (2020) -
Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess
por: Ng, Jennifer L, et al.
Publicado: (2023) -
Best Practice for Identification of Classical 21-Hydroxylase Deficiency Should Include 21 Deoxycortisol Analysis with Appropriate Isomeric Steroid Separation
por: Greaves, Ronda F., et al.
Publicado: (2023) -
Heterologous biosynthesis and manipulation of crocetin in Saccharomyces cerevisiae
por: Chai, Fenghua, et al.
Publicado: (2017)